240 related articles for article (PubMed ID: 31430625)
1. Separation and characterization of forced degradation products in homoharringtonine injection by UHPLC-Q-TOF-MS.
Gu X; Chen Y; Lou Y; Zheng J
J Pharm Biomed Anal; 2019 Nov; 176():112801. PubMed ID: 31430625
[TBL] [Abstract][Full Text] [Related]
2. Liquid chromatography/electrospray ionization tandem mass spectrometry study of repaglinide and its forced degradation products.
Purna Chander C; Raju B; Ramesh M; Shankar G; Srinivas R
Rapid Commun Mass Spectrom; 2018 Aug; 32(15):1181-1190. PubMed ID: 29723439
[TBL] [Abstract][Full Text] [Related]
3. LC/Q-TOF-MS-based structural characterization of enasidenib degradation products and establishment of a stability-indicating assay method: Insights into chemical stability.
Chakkar A; Chaturvedi S; Rajput N; Sengupta P; Sharma N
Rapid Commun Mass Spectrom; 2024 Mar; 38(5):e9696. PubMed ID: 38355880
[TBL] [Abstract][Full Text] [Related]
4. Analytical method development, identification, and characterization of stress degradation products of idelalisib by ultrahigh-performance liquid chromatography with photodiode array and ultrahigh-performance liquid chromatography with electrospray ionization quadrupole time-of-flight mass spectrometry studies.
Mahesh M; Bali A; Gupta T
Rapid Commun Mass Spectrom; 2024 Jun; 38(11):e9745. PubMed ID: 38591150
[TBL] [Abstract][Full Text] [Related]
5. Characterization of seven new related impurities and forced degradation products of tetracaine hydrochloride and proposal of degradation pathway by UHPLC-Q-TOF-MS.
Liu C; Luo Y; Tao Q; Hong L; Zeng S
J Pharm Biomed Anal; 2023 Jan; 223():115116. PubMed ID: 36343535
[TBL] [Abstract][Full Text] [Related]
6. Characterization of degradation products of macitentan under various stress conditions using liquid chromatography/mass spectrometry.
Yerra NV; Pallerla P; Pandeti S; Tabet JC; Thota JR
Rapid Commun Mass Spectrom; 2018 Jul; 32(13):1075-1084. PubMed ID: 29660192
[TBL] [Abstract][Full Text] [Related]
7. Validated stability indicating assay method of olaparib: LC-ESI-Q-TOF-MS/MS and NMR studies for characterization of its new hydrolytic and oxidative forced degradation products.
Thummar M; Kuswah BS; Samanthula G; Bulbake U; Gour J; Khan W
J Pharm Biomed Anal; 2018 Oct; 160():89-98. PubMed ID: 30075398
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of forced degradation products of sertraline hydrochloride using UPLC, ultra-high-performance liquid Chromatography-Quadrupole-Time of flight mass spectrometry (UHPLC-Q-TOF/MS/MS) and NMR.
Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2022 Nov; 221():115045. PubMed ID: 36126615
[TBL] [Abstract][Full Text] [Related]
9. Identification of forced degradation products of tamsulosin using liquid chromatography/electrospray ionization tandem mass spectrometry.
Namdev D; Borkar RM; Raju B; Kalariya PD; Rahangdale VT; Gananadhamu S; Srinivas R
J Pharm Biomed Anal; 2014 Jan; 88():245-55. PubMed ID: 24083958
[TBL] [Abstract][Full Text] [Related]
10. LC and LC-MS/MS studies for identification and characterization of new degradation products of ibrutinib and elucidation of their degradation pathway.
Mehta L; Naved T; Grover P; Bhardwaj M; Mukherjee D
J Pharm Biomed Anal; 2021 Feb; 194():113768. PubMed ID: 33279300
[TBL] [Abstract][Full Text] [Related]
11. Identification and characterization of stressed degradation products of prulifloxacin using LC-ESI-MS/Q-TOF, MSn experiments: development of a validated specific stability-indicating LC-MS method.
Raju B; Ramesh M; Srinivas R; Raju SS; Venkateswarlu Y
J Pharm Biomed Anal; 2011 Nov; 56(3):560-8. PubMed ID: 21783336
[TBL] [Abstract][Full Text] [Related]
12. Characterization of stress degradation products of nintedanib by UPLC, UHPLC-Q-TOF/MS/MS and NMR: Evidence of a degradation product with a structure alert for mutagenicity.
Dhiman V; Balhara A; Singh S; Tiwari S; Gananadhamu S; Talluri MVNK
J Pharm Biomed Anal; 2021 May; 199():114037. PubMed ID: 33836462
[TBL] [Abstract][Full Text] [Related]
13. Method validation and characterization of stress degradation products of azelastine hydrochloride using LC-UV/PDA and LC-Q/TOF-MS studies.
Shekhar S; Bali A
Rapid Commun Mass Spectrom; 2024 Apr; 38(7):e9712. PubMed ID: 38351666
[TBL] [Abstract][Full Text] [Related]
14. Structural characterization of alkaline and oxidative stressed degradation products of lurasidone using LC/ESI/QTOF/MS/MS.
Kumar Talluri MVN; Dharavath S; Kalariya PD; Prasanth B; Srinivas R
J Pharm Biomed Anal; 2015 Feb; 105():1-9. PubMed ID: 25527975
[TBL] [Abstract][Full Text] [Related]
15. Characterization of forced degradation products of ketorolac tromethamine using LC/ESI/Q/TOF/MS/MS and in silico toxicity prediction.
Kalariya PD; Raju B; Borkar RM; Namdev D; Gananadhamu S; Nandekar PP; Sangamwar AT; Srinivas R
J Mass Spectrom; 2014 May; 49(5):380-91. PubMed ID: 24809899
[TBL] [Abstract][Full Text] [Related]
16. Forced degradation of fingolimod: effect of co-solvent and characterization of degradation products by UHPLC-Q-TOF-MS/MS and 1H NMR.
Patel PN; Kalariya PD; Gananadhamu S; Srinivas R
J Pharm Biomed Anal; 2015 Nov; 115():388-94. PubMed ID: 26279369
[TBL] [Abstract][Full Text] [Related]
17. Study on forced degradation behaviour of dofetilide by LC-PDA and Q-TOF/MS/MS: Mechanistic explanations of hydrolytic, oxidative and photocatalytic rearrangement of degradation products.
Thalluri B; Dhiman V; Tiwari S; Baira SM; Kumar Talluri MVN
J Pharm Biomed Anal; 2020 Feb; 179():112985. PubMed ID: 31780282
[TBL] [Abstract][Full Text] [Related]
18. Identification and characterization of stressed degradation products of metoprolol using LC/Q-TOF-ESI-MS/MS and MS(n) experiments.
Borkar RM; Raju B; Srinivas R; Patel P; Shetty SK
Biomed Chromatogr; 2012 Jun; 26(6):720-36. PubMed ID: 21989963
[TBL] [Abstract][Full Text] [Related]
19. Isolation and structural characterization of degradation products of afatinib dimaleate by LC-Q-TOF/MS/MS and NMR: cytotoxicity evaluation of afatinib and isolated degradation products.
Chavan BB; Sawant V; Borkar RM; Ragampeta S; Talluri MVNK
J Pharm Biomed Anal; 2019 Mar; 166():139-146. PubMed ID: 30640044
[TBL] [Abstract][Full Text] [Related]
20. Characterization of forced degradation products of clozapine by LC-DAD/ESI-Q-TOF.
Skibiński R; Trawiński J; Komsta Ł; Bajda K
J Pharm Biomed Anal; 2016 Nov; 131():272-280. PubMed ID: 27611099
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]